AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA. Full abstracts can now be viewed on the ASN website at www.asn-online.org.

The three accepted abstracts are as follows:

  • “Hemoglobin Response by Baseline Hemoglobin and Iron Indices Following IV Ferumoxytol Treatment in Nondialysis CKD Patients” (Bolton et al.) – Abstract # 1088: Poster presentation;
    10 am-12 pm, Friday, October 30, 2009
  • “Gastrointestinal Tolerability of IV Ferumoxytol and Oral Iron Therapy in Patients with Iron Deficiency Anemia and Chronic Kidney Disease” (Spinowitz et al.) – Abstract #1093: Poster presentation; 10 am-12 pm, Friday, October 30, 2009
  • “MRI-Based Renal Imaging with Ferumoxytol: Perfusion-Enhanced MRI in a Rabbit Model” (Lewis et al.) – Abstract #2979: Poster presentation; 10 am-12 pm, Saturday, October 31, 2009

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Obesity medication liraglutide is safe and effective in children aged 6 to <12 years